STAT+: Bipartisan pair of senators calls on Congress to examine expensive new Alzheimer’s drug
WASHINGTON — Sens. Elizabeth Warren (D-Mass.) and Bill Cassidy (R-La.) want Congress to take a…
Category: Congress
Key Democrats slam FDA for failing to crack down on Juul and other e-cigarette makers
WASHINGTON — Congressional Democrats openly pressured acting Food and Drug Administration Commissioner Janet Woodcock to…
STAT+: Key science officials detail their plans for a new research agency — and Congress is getting closer to funding it
WASHINGTON — Two key federal health officials are pitching a new branch of the National…
.jpg)
STAT+: Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs
WASHINGTON — Sen. Ron Wyden (D-Ore.), the influential chair of the Senate Finance Committee, is…
STAT+: Lawmakers revive legislation to accelerate the development of new antibiotics
After months of anticipation, a bipartisan group of U.S. lawmakers is reintroducing bills in the…
STAT+: Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates
WASHINGTON — Sen. Chuck Grassley’s voice boomed through the Senate hearing room — it sounded…
STAT+: Senate finance chair investigates AbbVie over its corporate tax strategy
AbbVie, which is already being probed by congressional Democrats for its pricing practices, is now…
STAT+: Lawmakers pitch a bill to create $30 billion in ‘biobonds’ to jumpstart drug development
In a bid to jumpstart drug development, a bipartisan group of lawmakers introduced a bill…
STAT+: Health care providers hope to cash in through Congress’ new earmark process
WASHINGTON — Earmarks are back, and so is the health care industry’s insatiable appetite to…
STAT+: Democrats call on FTC to investigate AbbVie’s Humira pricing strategy
WASHINGTON — Three powerful Democrats wrote to the Federal Trade Commission Tuesday urging them to…
STAT+: Congress is ready to grill AbbVie’s CEO over drug pricing
WASHINGTON — AbbVie CEO Richard Gonzalez is in for a congressional tongue-lashing of outsized proportion….
STAT+: Abandoned Trump order on the bioeconomy highlights a path forward for Biden — but with mixed reviews
WASHINGTON — The Trump administration came remarkably close to shoring up the scattershot way the…
STAT+: Telehealth companies are fueling a lobbying frenzy to protect their Covid boom
WASHINGTON — Telehealth companies, flush with cash after the Covid-19 pandemic spiked both demand and…
STAT+: Key House Democrats’ push for a ‘bipartisan’ drug pricing bill could doom Pelosi’s signature legislation
WASHINGTON — A group of 10 moderate Democrats is urging House Speaker Nancy Pelosi to…
STAT+: Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms
WASHINGTON — Sen. Bob Menendez doesn’t face reelection until 2024, but pharmaceutical executives are already…
STAT+: Biden’s Medicaid pressure tactics could put his team at odds with hospitals
WASHINGTON — The Biden administration is pressuring states to expand Medicaid — and it’s setting…
STAT+: Top Senate Democrat heads back to drawing board on drug pricing
WASHINGTON — A powerful Democratic committee chair is starting to work on a new drug…
STAT+: Did someone say patent thicket? AbbVie CEO to testify before Congress about drug pricing tactics
As part of its probe into pharmaceutical industry pricing tactics, a Congressional committee next month…
STAT+: Lander fends off controversy, pledges broader access to STEM careers during Senate confirmation hearing
WASHINGTON — Eric Lander, President Biden’s nominee to lead the White House’s science policy office,…
In his biggest speech yet, Biden pitches a new health agency to help ‘end cancer as we know it’
WASHINGTON — In one of the most emotional moments of his first major address to…
Biden is set to ask for drug pricing reform this year. But it’s an empty call
WASHINGTON — President Biden is set to tell Congress tonight to let Medicare negotiate drug…
Opinion: H.R. 3’s international reference pricing misses the mark
The White House and Congress have declared that reining in Medicare prescription drug costs to…
STAT+: Drug pricing déjà vu: Now it’s Democrats struggling to unite on the issue
WASHINGTON — It’s the eve of a major speech by the president, and it’s anyone’s…
Opinion: Congress: stand up to the paper lobby and abolish outdated paper labeling for clinicians
There’s no place in health care for practices that fail to serve the best interests…
STAT+: Worried drug pricing reform might be left behind, Democrat pushes Biden to make clear his support
WASHINGTON — At least one Democratic lawmaker is openly pushing President Biden to include drug…
STAT+: Why hospitals hate Bernie Sanders’ latest health reform push
WASHINGTON — Progressives in Congress, led by Sen. Bernie Sanders, have ramped up pressure on…
STAT+: Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal
A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible…
Top Senate Republican holds up Biden’s CMS nominee over Texas Medicaid waiver
WASHINGTON — A top Senate Republican is holding up the confirmation of President Biden’s nominee…
STAT+: The lobbying juggernaut the American Hospital Association is losing its top advocate at a critical moment for the industry
WASHINGTON — Tom Nickels helped build the American Hospital Association into one of the biggest…
In Q&A, Vice President Harris calls for urgent action on the Black maternal health crisis
It’s an American crisis that was long ignored at the government’s highest levels: Black women…
.jpg)
STAT+: Hints emerge about a key Senate committee’s plans for health care
WASHINGTON — A Senate hearing Thursday provided one of the clearest roadmaps to date for…
STAT+: PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold…
STAT+: There’s no point person in Biden’s HHS for its $186 billion Covid-19 fund for health care providers
WASHINGTON — Health care providers are eagerly awaiting billions of dollars from a Covid-19 relief…
Former Biden, Trump advisers renew push to delay second Covid vaccine
WASHINGTON — As Covid-19 cases spike and coronavirus variants continue to spread, the Biden administration…
Resistance from health experts and business owners could doom ‘vaccine passports’ even before they launch
WASHINGTON — When it comes to decrying the concept of “vaccine passports,” conservatives have company….
STAT+: Here are the drug pricing policy options Democrats could use to pay for their next big legislative push
WASHINGTON — Democrats in Congress are already gearing up for their next big legislative push,…
After U.S. failures on Covid, Congress is working to prepare America to fight the next pandemic
WASHINGTON — Congress, in a rare show of bipartisanship, is gearing up to try to…
STAT+: Senate reaches deal to extend Medicare pay bump for health care providers through 2021
WASHINGTON — Senate leaders have reached an agreement to extend a Medicare pay bump for…
STAT+: Lawmakers introduce a bill to prevent Sacklers from using bankruptcy ‘loophole’ to evade liability
In a move directed at the owners of Purdue Pharma, a pair of Democratic lawmakers…
STAT+: Xavier Becerra’s 4 most urgent challenges as Biden’s soon-to-be HHS secretary
WASHINGTON — Xavier Becerra has survived the worst of a tense confirmation battle to become…
STAT+: Hospitals’ push to boost Medicare pay through December faces uncertain fate in the Senate
WASHINGTON — Hospitals successfully lobbied to get a House vote next week to prolong a…
With the ear of Joe Manchin, West Virginia hospitals helped secure billions in new Covid relief funds
WASHINGTON — West Virginia University Health System doesn’t have the name recognition of the Mayo…
STAT+: ‘We are on a collision course’: As virtual care booms, experts call for new health data privacy protections
A drop in your daily step count. A missed period. A loss of hearing. If…
Senate approves $1.9 trillion coronavirus relief bill
WASHINGTON (AP) — An exhausted Senate narrowly approved a $1.9 trillion Covid-19 relief bill Saturday…
STAT+: Lawmakers rail against huge tax breaks drug wholesalers get from opioid settlement
Three congressional lawmakers are examining the extent to which pharmaceutical wholesalers and a leading drug…
STAT+: Health care industry scores lobbying wins in Senate on drug pricing, provider funds, insurance subsidies
WASHINGTON — Health care industry lobbying groups are poised to score big wins in the…
The ‘other’ epidemic: Amid Covid-19, addiction experts fear Biden could back-burner the overdose crisis
WASHINGTON — There’s an epidemic sweeping the country, causing thousands of needless deaths each month…
STAT+: Republicans’ surprising Becerra attack: He’s not sympathetic enough to pharma
WASHINGTON — Republican senators on Tuesday blasted President Biden’s health secretary nominee using an unexpected…
STAT+: The questions Congress should ask Pfizer, Moderna, and Johnson & Johnson about the Covid-19 vaccines
WASHINGTON — Executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novavax will testify Tuesday…